Application YC di Catena Biosciences

Summer 2021Active

Catena Biosciences ha partecipato a Y Combinator nel batch Summer 2021 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.

Batch YC: Summer 2021
Settore: HealthcareTherapeutics
Dimensione team: 7
Stato: Active
Lanciata: 2021

Founder

Marco LobbaFounder
Matthew FrancisFounder

Cosa fa Catena Biosciences

Catena’s technology lets us attach any two proteins together using an enzyme and the native amino acids tyrosine and cysteine within target proteins. It is a true platform technology because it enables the joining of any two soluble proteins together with minimal engineering and without restrictions due to protein size or complexity. Our work has already been used to modify cancer specific antibodies, CRISPR proteins and even cell surfaces. Our ability to produce modular protein therapeutics in a fraction of the time allows for true library creation across the therapeutics spectrum from oncology, vaccines, inflammatory disease and beyond.

Application YC di Catena Biosciences, ricostruita

Domanda per Y Combinator

Catena Biosciences, batch Summer 2021. Le vere domande del form, risposte da dati pubblici.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Catena Biosciences

Describe what your company does in 50 characters or less.

Using protein coupling to build new therapies

What is your company going to make? Please describe your product and what it does or will do.

We built a protein coupling technology that lets us attach any two proteins together through an enzyme that targets tyrosine and cysteine amino acids natively present in the proteins. Unlike traditional methods, we don't engineer each protein extensively or have restrictions on size or complexity. This allows us to rapidly create modular protein therapeutics for oncology, vaccines, inflammatory diseases, and more.

Where do you live now, and where would the company be based after YC?

We live and work in Berkeley, California, and the company would remain based here after YC.

Explain your decision regarding location.

Berkeley has a strong biotech ecosystem and access to academic labs and talent we rely on. We're well situated near collaborators and in a hub of innovation for therapeutics development.

21 risposte in più nell'application completa

Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.

Vedi domanda completa

Domande Frequenti

Questa è l'application YC reale di Catena Biosciences?

No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di Catena Biosciences (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come Catena Biosciences si presenterebbe a YC, non il testo che hanno inviato.

A quale batch YC apparteneva Catena Biosciences?

Catena Biosciences apparteneva al batch Summer 2021 di Y Combinator.

Chi ha fondato Catena Biosciences?

Catena Biosciences è stato fondato da Marco Lobba, Matthew Francis.

Cosa fa Catena Biosciences?

Using protein coupling to build new therapies

Come leggo la ricostruzione completa della application?

Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di Catena Biosciences, e di ogni altro batch YC, è in YC Insights.